Significant Ownership of Mark E. Strome

Location: Santa Monica, CA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Mark E. Strome.

Notify me when Mark E. Strome files a new Schedule 13D/G report.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ZIVO	Zivo Bioscience, Inc.	Common Stock, par value $.001 per share	12%	$53,142		442,854		Mark E. Strome	26 Dec 2024
CUE	Cue Biopharma, Inc.	Common Stock, $0.001 par value per share	5%	$1,862,968		2,166,242		Mark E. Strome	14 Nov 2022

Schedules 13D/G Reported by Mark E. Strome:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.